clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT04545866 |
P6099 | clinical trial phase | phase III clinical trial | Q42824827 |
P767 | contributor to the creative work or subject | Eunice Kennedy Shriver National Institute of Child Health and Human Development | Q5409765 |
P17 | country | United States of America | Q30 |
P582 | end time | 2023-03-31 | |
P1050 | medical condition | bronchopulmonary dysplasia | Q922640 |
P1132 | number of participants | 1160 | |
P4844 | research intervention | poractant alfa | Q15708403 |
pulmonary surfactant | Q28163641 | ||
budesonide | Q422212 | ||
P6153 | research site | Stanford University | Q41506 |
University of Rochester | Q149990 | ||
University of Pennsylvania | Q49117 | ||
Duke University | Q168751 | ||
Ohio State University | Q309331 | ||
University of Iowa Health Care | Q30254145 | ||
UNM Los Lunas | Q30258334 | ||
University of Utah Health Care | Q56582915 | ||
University of Alabama | Q492318 | ||
Emory University | Q621043 | ||
Case Western Reserve University | Q1047060 | ||
P8005 | research subject recruitment status | recruiting | Q76649708 |
P1813 | short name | BiB | |
P580 | start time | 2021-03-15 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | Randomized Controlled Trial of Budesonide + Surfactant Versus Surfactant Alone in Extremely Preterm Infants ("The Budesonide in Babies (BiB) Trial") |
Search more.